UnitedHealthcare Connecticut Anxiety Treatment Coverage | Klarity Health

Last updated: July 4, 2026

If you have UnitedHealthcare (UHC) coverage in Connecticut and are considering online anxiety treatment, understanding your plan’s benefits can help you make informed decisions before booking care. Connecticut’s mental health parity law and telehealth parity protections may extend meaningful coverage to anxiety treatment — including care delivered via telehealth — though specific benefits vary by plan type and employer.

Check if your UnitedHealthcare plan may cover anxiety treatment in Connecticut →

Connecticut Mental Health Parity Law and UnitedHealthcare

Connecticut’s mental health parity statute, CGS § 38a-514b, requires fully insured health plans to cover mental health and substance use disorder (MH/SUD) benefits at parity with medical and surgical benefits. This means UHC cannot impose more restrictive prior authorization requirements, visit limits, or cost-sharing on anxiety treatment than it applies to comparable medical care.

Connecticut also maintains telehealth parity requirements, meaning UHC fully insured plans must reimburse covered telehealth mental health services at the same rate as in-person visits. For many Connecticut members, this makes online anxiety treatment through providers like Klarity Health accessible without added cost.

Important: These parity protections apply to fully insured plans regulated by the Connecticut Insurance Department (CID). Self-funded employer plans governed by ERISA are not subject to Connecticut state parity law — they follow federal Mental Health Parity and Addiction Equity Act (MHPAEA) rules instead. If your coverage comes through a large employer, your plan is likely self-funded and may have different benefit structures than a state-regulated plan. Check your Summary Plan Description (SPD) or call UHC at the number on your member ID card to confirm.

UnitedHealthcare Plan Types Available in Connecticut

Your specific UHC plan type determines how you access anxiety treatment:

• PPO / EPO plans: No referral required to see a mental health provider. You can book directly with an in-network telehealth provider. EPO plans limit coverage to in-network providers.
• HMO plans: Typically require a referral from your primary care physician (PCP) before seeing a mental health specialist. Confirm referral requirements before booking.
• Medicare Advantage (UHC) plans: Mental health benefits are governed by CMS (Centers for Medicare & Medicaid Services) rules. Connecticut state parity law does not apply. Coverage for anxiety treatment may differ from commercial plans — review your Evidence of Coverage (EOC) document.
• Access Health CT exchange plans: Plans purchased through Connecticut’s state marketplace (Access Health CT) must cover mental health treatment as an Essential Health Benefit (EHB). Anxiety treatment, including telehealth visits, is typically included. Cost-sharing varies by metal tier (Bronze, Silver, Gold, Platinum).

UnitedHealthcare Formulary for Anxiety Medications in Connecticut

Most anxiety treatment plans include medication management alongside therapy. The following reflects general UHC formulary patterns for anxiety medications, though your specific plan’s formulary (the drug coverage list) governs what is covered and at what cost. Always verify coverage at uhcprovider.com or by calling member services.

SSRIs (First-Line Anxiety Treatment)

Selective serotonin reuptake inhibitors are the most commonly prescribed first-line medications for anxiety disorders. On most UHC plans:

• Generic SSRIs (fluoxetine, sertraline, escitalopram, citalopram, paroxetine): Typically Tier 1–2. Prior authorization generally not required. These are the most cost-effective option for most members.
• Brand-name SSRIs (Lexapro brand, Paxil brand, Zoloft brand): Typically Tier 3–4. Step therapy may be required — meaning your plan may require a trial of the generic equivalent before approving the brand name.

SNRIs (Second-Line or Alternative)

• Generic SNRIs (venlafaxine ER, duloxetine): Typically Tier 1–2, no prior authorization required on most plans.
• Brand SNRIs (Effexor XR, Cymbalta): Typically Tier 3–4 with step therapy. Generic venlafaxine ER or duloxetine trial typically required before brand approval.
• Pristiq (desvenlafaxine): No generic equivalent; Tier 3–4 with PA required on most UHC plans.

Benzodiazepines (Controlled Substance — Schedule IV)

Benzodiazepines (such as alprazolam/Xanax, clonazepam/Klonopin, lorazepam/Ativan, diazepam/Valium) are Schedule IV controlled substances. UHC applies specific coverage rules to this class:

• Quantity limits apply — typically a 30-day supply maximum per fill.
• Prior authorization is often required for long-term use (typically beyond 30–90 days continuous therapy).
• Early refill restrictions apply: controlled substances generally cannot be refilled before a standard early-refill window.
• Short-term, acute use at low doses may not require PA on all plans. Confirm with your plan before prescribing.

UHC’s controlled substance policies reflect both formulary design and state/federal regulations. Connecticut does not have state-specific benzo prescribing restrictions beyond federal DEA rules, but UHC’s internal utilization management may limit long-term coverage.

Non-Controlled Anxiolytics

• Buspirone: Generic buspirone is typically Tier 1, no prior authorization required on most UHC plans. It is non-controlled and commonly used for generalized anxiety disorder (GAD). A cost-effective option for patients who cannot use SSRIs or prefer non-controlled medications.
• Hydroxyzine (Vistaril, Atarax): Generic hydroxyzine pamoate and hydroxyzine HCl are typically Tier 1–2, no PA required. Commonly used for acute anxiety and insomnia-related anxiety. Non-controlled.
• Pregabalin (Lyrica): Generic pregabalin became available in 2019 and is typically Tier 2–3. Brand Lyrica is Tier 4 with step therapy (generic pregabalin trial required). Note: pregabalin is Schedule V — some plans apply quantity limits.

Beta-Blockers (Situational Anxiety)

• Propranolol (generic): Typically Tier 1, no PA required. Commonly prescribed off-label for situational/performance anxiety (e.g., public speaking, presentations). Non-controlled and generally well-tolerated.
• Atenolol (generic): Tier 1 on most plans, used similarly for situational anxiety.

Other Antidepressants Used for Anxiety

• Mirtazapine (generic): Tier 1–2, typically no PA required. Used for anxiety with comorbid insomnia or appetite loss.
• Viibryd (vilazodone): Brand-only (no generic as of 2026). Tier 3–4 with PA required on most UHC plans. Step therapy (SSRI trial) typically required.
• Trintellix (vortioxetine): Brand-only. Tier 3–4 with PA required. Step therapy required. Higher cost-sharing even with PA approval.

Prior Authorization and Step Therapy for Anxiety Medications

UHC uses prior authorization (PA) and step therapy protocols to manage costs and promote evidence-based prescribing. For anxiety medications, PA is most commonly required for:

• Long-term benzodiazepine use (typically beyond initial acute supply)
• Brand-name SSRIs/SNRIs when a generic equivalent is available
• Newer brand-only medications (Viibryd, Trintellix, Pristiq)
• Pregabalin (brand Lyrica)

Standard PA review timelines are 2–5 business days. Expedited review (within 72 hours) is available when a standard timeline would seriously jeopardize your health or ability to receive treatment.

If PA is denied, you have the right to appeal. UHC’s internal appeal process is the first step; if the internal appeal is denied, you may request an external independent review under Connecticut state law (for fully insured plans) or ERISA procedures (for self-funded plans).

What to Do If UHC Denies Your Anxiety Medication Claim

1. Request a written denial with reason code from UHC (required by law).
2. File an internal appeal within the timeframe noted in your denial letter (typically 180 days).
3. Request external review if internal appeal is denied. Connecticut Insurance Department (CID) administers external reviews for fully insured plans. Contact CID at 1-800-203-3447 or visit portal.ct.gov/cid.
4. ERISA plans: External review is available through a federally approved independent review organization (IRO) if your plan is self-funded. Contact the U.S. Department of Labor’s Employee Benefits Security Administration (EBSA) at 1-866-444-3272 for guidance.

Access Anxiety Treatment at Klarity Health

Klarity Health connects Connecticut residents with licensed providers for online anxiety treatment — no long wait lists and no commute required. Our network of 2,000+ licensed providers includes nurse practitioners and physicians who can evaluate your symptoms, discuss medication options, and provide ongoing care entirely via telehealth.

Check if your UnitedHealthcare plan may cover anxiety treatment in Connecticut →

Coverage varies by plan. We recommend verifying your specific benefits before your first appointment. Our team can help guide you through the process.

Frequently Asked Questions

Does UnitedHealthcare cover online anxiety treatment in Connecticut?

UHC fully insured plans in Connecticut may cover telehealth anxiety treatment under CGS § 38a-514b mental health parity requirements. Connecticut’s telehealth parity law also requires that covered telehealth services be reimbursed at the same rate as in-person visits. Coverage varies by plan — verify your specific benefits before booking.

Does UHC cover Xanax or other benzodiazepines for anxiety?

Generic benzodiazepines (alprazolam, clonazepam, lorazepam, diazepam) are typically covered on UHC plans but with quantity limits (usually 30-day supply per fill) and PA requirements for long-term use. Short-term prescriptions at initial doses may not require PA on all plans. Your specific formulary governs coverage.

Does UHC require step therapy for anxiety medications?

Yes, for brand-name SSRIs, SNRIs, and newer brand-only medications, UHC typically requires a trial of a generic equivalent before approving the brand name. Your provider can initiate a PA exception request if a generic is medically inappropriate for you.

Is buspirone covered by UnitedHealthcare?

Generic buspirone is typically Tier 1 on UHC plans with no prior authorization required, making it one of the most accessible and cost-effective anxiety medications in the UHC formulary.

Does Connecticut’s parity law apply to my UHC plan?

CGS § 38a-514b applies to fully insured UHC plans regulated by the Connecticut Insurance Department. If your coverage comes through a self-funded employer plan (common at large companies), Connecticut parity law does not apply — federal MHPAEA rules govern instead. Check your SPD or call UHC to confirm your plan type.

How do I file a complaint about UHC anxiety coverage in Connecticut?

For fully insured plans, contact the Connecticut Insurance Department (CID) at 1-800-203-3447. For self-funded ERISA plans, contact the U.S. Department of Labor EBSA at 1-866-444-3272.

Coverage availability and formulary details vary by plan and are subject to change. This page is for informational purposes only. Always verify your specific benefits with UnitedHealthcare before booking care. Klarity Health does not guarantee insurance coverage.

See if you may qualify for online anxiety treatment at Klarity Health →